179 related articles for article (PubMed ID: 24361533)
1. Application of the CellDetect® staining technique in diagnosis of human cervical cancer.
He S; Wang GL; Zhu YY; Wu MH; Ji ZG; Seng J; Ji Y; Zhou JM; Chen L
Gynecol Oncol; 2014 Feb; 132(2):383-8. PubMed ID: 24361533
[TBL] [Abstract][Full Text] [Related]
2. Novel dual-function CellDetect® staining technology: wedding morphology and tinctorial discrimination to detect cervical neoplasia.
Idelevich P; Elkeles A; Okon E; Kristt D; Terkieltaub D; Rivkin I; Bruchim I; Fishman A
Diagn Pathol; 2010 Nov; 5():70. PubMed ID: 21070653
[TBL] [Abstract][Full Text] [Related]
3. Screening for cervical neoplasia: a community-based trial comparing Pap staining, human papilloma virus testing, and the new bi-functional Celldetect® stain.
Idelevich P; Kristt D; Schechter E; Lew S; Elkeles A; Terkieltaub D; Rivkin I; Bruchim I; Fishman A
Diagn Cytopathol; 2012 Dec; 40(12):1054-61. PubMed ID: 21630482
[TBL] [Abstract][Full Text] [Related]
4. p16INK4A as a marker for cervical dyskaryosis: CIN and cGIN in cervical biopsies and ThinPrep smears.
Murphy N; Ring M; Killalea AG; Uhlmann V; O'Donovan M; Mulcahy F; Turner M; McGuinness E; Griffin M; Martin C; Sheils O; O'Leary JJ
J Clin Pathol; 2003 Jan; 56(1):56-63. PubMed ID: 12499437
[TBL] [Abstract][Full Text] [Related]
5. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions.
Juric D; Mahovlić V; Rajhvajn S; Ovanin-Rakić A; Skopljanac-Macina L; Barisić A; Projić IS; Babić D; Susa M; Corusić A; Oresković S
Coll Antropol; 2010 Mar; 34(1):19-24. PubMed ID: 20432728
[TBL] [Abstract][Full Text] [Related]
6. Comparison of the sensitivity and specificity of p16/Ki-67 dual staining and HPV DNA testing of abnormal cervical cytology in the detection of histology proven cervical intraepithelial neoplasia grade 2 and above (CIN 2+).
Tay TKY; Lim KL; Hilmy MH; Thike AA; Goh ST; Song LH; Hwang JSG; Mantoo S
Malays J Pathol; 2017 Dec; 39(3):257-265. PubMed ID: 29279588
[TBL] [Abstract][Full Text] [Related]
7. p16(INK4a) as a complementary marker of high-grade intraepithelial lesions of the uterine cervix. I: Experience with squamous lesions in 189 consecutive cervical biopsies.
Dray M; Russell P; Dalrymple C; Wallman N; Angus G; Leong A; Carter J; Cheerala B
Pathology; 2005 Apr; 37(2):112-24. PubMed ID: 16028838
[TBL] [Abstract][Full Text] [Related]
8. CINtec® PLUS dual immunostain: a triage tool for cervical pap smears with atypical squamous cells of undetermined significance and low grade squamous intraepithelial lesion.
Loghavi S; Walts AE; Bose S
Diagn Cytopathol; 2013 Jul; 41(7):582-7. PubMed ID: 22833355
[TBL] [Abstract][Full Text] [Related]
9. Expression of MN/CA9 protein in Papanicolaou smears containing atypical glandular cells of undetermined significance is a diagnostic biomarker of cervical dysplasia and neoplasia.
Liao SY; Stanbridge EJ
Cancer; 2000 Mar; 88(5):1108-21. PubMed ID: 10699902
[TBL] [Abstract][Full Text] [Related]
10. Application of human papillomavirus in screening for cervical cancer and precancerous lesions.
Wang JL; Yang YZ; Dong WW; Sun J; Tao HT; Li RX; Hu Y
Asian Pac J Cancer Prev; 2013; 14(5):2979-82. PubMed ID: 23803065
[TBL] [Abstract][Full Text] [Related]
11. The utility of p16INK4a and Ki-67 staining on cell blocks prepared from residual thin-layer cervicovaginal material.
Akpolat I; Smith DA; Ramzy I; Chirala M; Mody DR
Cancer; 2004 Jun; 102(3):142-9. PubMed ID: 15211472
[TBL] [Abstract][Full Text] [Related]
12. Clinical value of fully automated p16/Ki-67 dual staining in the triage of HPV-positive women in the Norwegian Cervical Cancer Screening Program.
Ovestad IT; Dalen I; Hansen E; Loge JL; Dybdahl BM; Dirdal MB; Moltu P; Berland JM
Cancer Cytopathol; 2017 Apr; 125(4):283-291. PubMed ID: 27918650
[TBL] [Abstract][Full Text] [Related]
13. A thin-layer, liquid-based pap test for mass screening in an area of China with a high incidence of cervical carcinoma. A cross-sectional, comparative study.
Pan Q; Belinson JL; Li L; Pretorius RG; Qiao YL; Zhang WH; Zhang X; Wu LY; Rong SD; Sun YT
Acta Cytol; 2003; 47(1):45-50. PubMed ID: 12585030
[TBL] [Abstract][Full Text] [Related]
14. Immunocytochemical detection of raf kinase inhibitor protein and human papillomavirus profiling of normal and abnormal cervical ThinPrep samples.
Al-Awadhi R; Husain S; Chehadeh W; Al-Jassar W; Kapila K; Al-Mulla F
Acta Cytol; 2013; 57(3):259-65. PubMed ID: 23636063
[TBL] [Abstract][Full Text] [Related]
15. Early non-invasive diagnosis of cervical cancer: beyond Pap smears and human papilloma virus (HPV) testing.
Mathur SP; Mathur RS; Creasman WT; Underwood PB; Kohler M
Cancer Biomark; 2005; 1(2-3):183-91. PubMed ID: 17192039
[TBL] [Abstract][Full Text] [Related]
16. [Combining high-risk human papillomavirus DNA test and cytological test to detect early cervical dysplasia].
Qian DY; Cen JM; Wang D; Zeng RH; Lin AH; Shu YH; Hong DH; Huang ZH
Zhonghua Fu Chan Ke Za Zhi; 2006 Jan; 41(1):34-7. PubMed ID: 16635326
[TBL] [Abstract][Full Text] [Related]
17. Diagnostic accuracy of novel folate receptor-mediated staining solution detection (FRD) for CIN2+: A systematic review and meta analysis.
Li YX; Luo HX; Wang W; Wang Z; Zhao WH; Hao M
Medicine (Baltimore); 2021 May; 100(20):e26004. PubMed ID: 34011097
[TBL] [Abstract][Full Text] [Related]
18. Screening properties of human papillomavirus testing for predicting cervical intraepithelial neoplasia in atypical squamous cells of undetermined significance and low-grade squamous intraepithelial lesion smears: a prospective study.
Dane C; Batmaz G; Dane B; Cetin A
Ann Diagn Pathol; 2009 Apr; 13(2):73-7. PubMed ID: 19302953
[TBL] [Abstract][Full Text] [Related]
19. Interobserver reproducibility and accuracy of p16/Ki-67 dual-stain cytology in cervical cancer screening.
Wentzensen N; Fetterman B; Tokugawa D; Schiffman M; Castle PE; Wood SN; Stiemerling E; Poitras N; Lorey T; Kinney W
Cancer Cytopathol; 2014 Dec; 122(12):914-20. PubMed ID: 25132656
[TBL] [Abstract][Full Text] [Related]
20. Can Genomic Amplification of Human Telomerase Gene and C-MYC in Liquid-Based Cytological Specimens Be Used as a Method for Opportunistic Cervical Cancer Screening?
Gao K; Eurasian M; Zhang J; Wei Y; Zheng Q; Ye H; Li L
Gynecol Obstet Invest; 2015; 80(3):153-63. PubMed ID: 25832290
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]